G95D (p.Gly95Asp) variant of NLGN3 (Neuroligin-3)
G95D (p.Gly95Asp) in NLGN3 (Neuroligin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.54 / 1. The record also includes structural context.
G95D (p.Gly95Asp) variant details
- p.Gly95Asp
- rs917449837
- NCI-TCGA Cosmic COSV1007
- cosmic curated COSV10070
- Ensembl rs917449837
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.543
- AlphaMissense 0.30
- MetaLR 0.48
- MetaSVM 0.18
- PolyPhen-2 0.97
- SIFT 0.00
- EVE 0.54
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available